Infertility. Female infertility of other origin
Conditions
Interventions
Intervention 1: Intervention group: Tablet 250mg/day one month before IUI cycle willbe used by patients. Intervention 2: Control group: Tablet placebo onece daily one month before IUI cycle willbe u
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 39 Years
Inclusion criteria
Inclusion criteria: Patients who are Candidate for IUI with endometrial thickness<7mm in vaginal ultrasound At least one tubal patency at hSG
Exclusion criteria
Exclusion criteria: Hypertension Diabetes Any endocrinological or underlying disease Hypersensitivity to ginger AMH<1
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive BhCG 14 days after IUI. Timepoint: 14 days after IUI. Method of measurement: BhCGmu/dl. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: Two weeks after IUI. Method of measurement: BhCG levels. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Davari Tanha
Tehran University of Medical Sciences
Outcome results
None listed